EN
Home/Australia/Blog/What do GLP-1 medicines cost in Australia? PBS scripts, private scripts and the costs around them
AUAustralia Prices and costs

What do GLP-1 medicines cost in Australia? PBS scripts, private scripts and the costs around them

How a PBS script differs from a private one, why the dose changes what you pay, and the doctor and insurance costs that sit around the medicine. No price list: here is why.

Written for Australia. Reading from India? India version

The short answer

It depends on the script. A PBS script costs you a capped co-payment, and the government pays the rest. A private script costs the full price the pharmacy sets. GLP-1 medicines are subsidised only for type 2 diabetes, under strict criteria. Every weight-loss script in Australia is private.

Key takeaways

  • A PBS script costs you a capped co-payment, lower with a concession card, and the government pays the rest of the price.1
  • Only two GLP-1 medicines are on the PBS, Ozempic and Trulicity, and only for type 2 diabetes that meets set criteria.2,3
  • No GLP-1 medicine is PBS-subsidised for weight, so Wegovy and Mounjaro for weight are always private scripts at full price.4,5
  • A Mounjaro KwikPen or Wegovy FlexTouch pen holds 4 weekly doses, so a year of weekly doses uses 13 pens.6,7
  • In the Australian label’s weight trials, 38 in 100 people on Wegovy had nausea, against 14 in 100 on a dummy injection.7
Before you go further
  • GLP-1 medicines are prescription-only in Australia. A doctor decides whether one fits, which one and at what dose.8
  • Ozempic is approved for type 2 diabetes, not weight loss. Promoting it for weight loss is illegal in Australia.8
  • This page shows no prices and names no seller or clinic. The next section explains why.
On this page
  1. Why doesn’t this page list prices?
  2. What does a PBS script cost you?
  3. What does a private script cost you?
  4. How many pens does a year take?
  5. What other costs come with it?
  6. Questions people ask
  7. How we researched this
  8. Sources

Why doesn’t this page list prices?

Australian rules treat price information for prescription medicines as advertising, and only pharmacies and a few approved doctors may publish it.9

The TGA (Therapeutic Goods Administration) regulates medicine advertising. Its guidance says price information “can only be produced and distributed by” community pharmacists, pharmacy marketing groups and certain approved doctors.9 Even they must publish lists of 25 medicines or more, in alphabetical order, with no claims.9

We are an independent guide, not a pharmacy. So we explain how the costs work and where the official figures live. For today’s PBS charges, the PBS website publishes the current patient fees.1

The rule has a purpose. The TGA says permitted price lists help “promote competition amongst retailers”, without steering you to one medicine.9 The PBS website notes that prices can vary from one pharmacy to the next, even for PBS medicines.

What does a PBS script cost you?

A capped co-payment per script, lower if you have a concession card, with the government paying the rest of the medicine’s price.1

The PBS (Pharmaceutical Benefits Scheme) sets a general co-payment and a lower concession co-payment. The general amount is indexed each 1 January from 2027; the concession amount stays the same until 2029.1 The PBS Safety Net lowers what you pay once a family’s PBS spending passes a yearly threshold.1

For GLP-1 medicines, a PBS script exists only for type 2 diabetes. The PBS lists Ozempic and Trulicity, under criteria that include an HbA1c above 7%.2,3 A first Ozempic script needs a telephone or online authority from the doctor.3,10

GLP-1 medicines are also excluded from 60-day dispensing, which covers most other diabetes medicines.3 So each PBS supply covers about a month, with its own co-payment. Our post on Ozempic and the PBS criteria walks through each rule.

What does a private script cost you?

The full price, with no government subsidy. The pharmacy sets it, and it usually goes up with the strength of the pen.1,11

Every GLP-1 script for weight is private. Wegovy was not PBS-listed on 1 October 2026, and Mounjaro’s listing process had ceased.4,5 A doctor can also write a private script for a PBS medicine if you don’t meet its criteria.

Price rises with dose. In the price table of the 2024 Australian Obesity Management Algorithm, higher-strength Wegovy and Mounjaro pens cost more than starting-strength pens.11 As your dose climbs, so does your pharmacy bill.

The highest Wegovy dose costs more again. The 7.2 mg weekly dose is given as 3 injections of 2.4 mg, so it uses three times the medicine of a 2.4 mg week.7 See Wegovy 7.2 mg in Australia.

Free toolAsk about cost before you start

Add questions on the dose plan, PBS rules and review dates to take to your GP. No sign-up.

Open the list

How many pens does a year take?

Thirteen. A Mounjaro KwikPen and a Wegovy FlexTouch pen each hold 4 weekly doses, and a year has 52 weeks.6,7

Budget in pens, not months. Twelve “monthly” pens cover only 48 weeks, so a year needs 13.6,7

The first pens are lower strengths. Mounjaro starts at 2.5 mg for 4 weeks, then 5 mg, rising in 2.5 mg steps of at least 4 weeks.6 Wegovy climbs over 16 weeks through 0.25, 0.5, 1 and 1.7 mg to 2.4 mg.7

So the first few months often cost less than later ones. Your prescriber may move more slowly or stop at a lower dose. Australian guidance says weight medicines “will usually be required long-term”, so price the second year too.11

RisksThe risks, in brief
  • Stomach effects. In the weight trials in the Australian label, 38 in 100 people on Wegovy felt sick (nausea), against 14 in 100 on a dummy injection. On Mounjaro it was 25 to 29 in 100, against about 9 in 100. It mostly happens while the dose goes up.6,7
  • Gallstones. They were reported in 16 in 1,000 people on Wegovy, against 11 in 1,000 on a dummy injection.7
  • Pancreatitis (an inflamed pancreas) has been reported with these medicines. The typical sign is sudden, severe pain in the upper belly that may spread to the back.6,7,12
  • Dehydration. Vomiting or diarrhoea can dry you out, which in rare cases harms the kidneys.7
  • Pregnancy. Semaglutide and tirzepatide are pregnancy category D in Australia. The Wegovy label says to stop at least 2 months before a planned pregnancy.7,11
Full detail in our side effects guide →
Get help now: call triple zero (000) for sudden, severe belly pain that won’t go away, with or without vomiting. It can be pancreatitis. Not sure? Call healthdirect on 1800 022 222, any time.12,13

What other costs come with it?

Doctor visits, and sometimes a telehealth program fee. Medicare pays a rebate for telehealth only when the doctor is your eligible telehealth practitioner.14

Your GP. Medicare rebates a GP visit in person. For a telehealth rebate, the doctor or practice must have seen you face to face in the past 12 months. Being registered with the practice through MyMedicare also counts.14

Online services. Many weight services are private and charge their own fees. Our post on getting a script online covers what a proper consult looks like.

Insurance. Some private health extras policies pay a part of a private script, and some exclude weight-loss medicines. See private health insurance and GLP-1s.15,16

Questions people ask

How much is Mounjaro in Australia?

Mounjaro is private-only, so the pharmacy sets the price, and it rises with pen strength. We don’t publish prices: Australian rules treat them as advertising.5,9,11

Is Ozempic cheaper on the PBS?

For people with type 2 diabetes who meet the PBS criteria, yes. You pay the PBS co-payment instead of the full price.1,3

Can I get Ozempic on the PBS for weight loss?

No. Ozempic is PBS-listed for type 2 diabetes only, and advertising it for weight loss is illegal.2,8

Why do pharmacies charge different prices?

Private prices aren’t fixed by the government. The TGA says permitted price lists exist to promote competition between retailers.9

Does the PBS Safety Net cover private scripts?

Probably not. The PBS says the Safety Net counts what you spend on PBS medicines, veterans’ PBS medicines and public-hospital outpatient medicines. Private scripts are not on that list, so ask your pharmacist if you’re unsure.1

How we researched this

We checked every source on 12 October 2026. They include the PBS fees page, diabetes tables, criteria diagram and medicine-status pages, and the Australian Wegovy and Mounjaro labels.

We publish no prices. The TGA’s price-information guidance limits who may publish prescription-medicine prices, and we are not a pharmacy. The pen count is our arithmetic: 52 weekly doses ÷ 4 doses per pen = 13 pens.

Before you move on

  • Ask whether any PBS criteria apply to you.
  • Count 13 pens a year, not 12.
  • Ask your pharmacy for its price at each dose strength.
  • Check whether your extras cover pays anything.
  • Budget for a second year.

More from the Australia blog

About GLP Guidebook

The monthly Australia update

An independent guide to GLP‑1 medicines. We don’t sell medicines, take drug-company money, earn commissions or link to any provider. Once a month: PBS decisions, TGA approvals and safety alerts. How we write

Was this post easy to understand?

Sources

  1. Pharmaceutical Benefits Scheme. What are the current patient fees and charges? Link
  2. Pharmaceutical Benefits Scheme. PBS restrictions for type 2 diabetes: summary tables, April 2025. Link
  3. Pharmaceutical Benefits Scheme. PBS-subsidised pharmacotherapy for type 2 diabetes (restrictions at 1 December 2024). Link
  4. Pharmaceutical Benefits Scheme. Medicine status: semaglutide (Wegovy), established cardiovascular disease with obesity, November 2025 PBAC meeting. Information current at 1 October 2026; page last updated 23 July 2026. Link
  5. Pharmaceutical Benefits Scheme. Medicine status: tirzepatide (Mounjaro), type 2 diabetes, March 2026 PBAC meeting. Information current at 1 October 2026; page last updated 30 September 2026. Link
  6. Eli Lilly. Mounjaro Australian Product Information, version A14.0. Date of revision 2 October 2026. Link
  7. Novo Nordisk. Wegovy Australian Product Information. Date of revision 22 June 2026. Link
  8. TGA. Advertising Ozempic and GLP-1 receptor agonists is prohibited. Last updated 11 March 2025. Link
  9. TGA. Applying the Advertising Code rules: price information. Last updated 21 July 2026. Link
  10. Pharmaceutical Benefits Scheme. Item 12075M: semaglutide 1.34 mg/mL injection, 1 × 3 mL pen (Ozempic), first PBS prescription. Link
  11. Australian Diabetes Society with ANZOS, ANZMOSS and RACGP. Australian Obesity Management Algorithm. July 2024. Link
  12. healthdirect. Pancreatitis. Link
  13. healthdirect. How healthdirect can help you (triple zero and the 1800 022 222 helpline). Link
  14. Department of Health, Disability and Ageing (MBS Online). Medical practitioners: non-referred MBS telehealth services, factsheet. Last updated 23 October 2025. Link
  15. HIF. Can you claim for weight loss drugs on your Extras cover? Health Hub, 2026. Link
  16. HCF. Drugs and health cover: what you can and can’t claim. Health Agenda. Link

Last checked 12 Oct 2026 · Next review due 12 Apr 2027 · Report an error

How this post was made. Written by the GLP Guidebook team from the sources above. It’s general information, not medical advice. Talk to your GP, pharmacist or prescriber before starting, stopping or changing any medicine. We don’t sell, prescribe or recommend any brand or provider. How we write